Metabolic and endocrine aspects of the ketogenic diet

Epilepsy Research

Volumn 37, Issue 3, 1999, Pages

  Sankar, Raman ^a   Sotero De Menezes, Marcio ^b  

^a Department of Social Work   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Antiepileptic drugs; Carnitine; Energy metabolism; Epilepsy; Ketogenic diet; Lipid metabolism; Metabolic disease; Patient selection; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CARNITINE;

CARNITINE DEFICIENCY; CONFERENCE PAPER; DIET; EPILEPSY; FATTY ACID METABOLISM; HUMAN; KETOGENESIS; LIPID METABOLISM; LIPOLYSIS; MITOCHONDRION; NEPHROLITHIASIS; PRIORITY JOURNAL; SEIZURE; SUPPLEMENTATION;

3-HYDROXYBUTYRIC ACID; ANTICONVULSANTS; CARNITINE; DIETARY FATS; ENERGY METABOLISM; EPILEPSY; FATTY ACIDS; FOOD-DRUG INTERACTIONS; GLUCAGON; HUMANS; INSULIN; KETONE BODIES; KETOSIS; OXIDATION-REDUCTION; PATIENT SELECTION;

EID: 18844464366     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(99)00071-6     Document Type: Conference Paper

References (30)

1. Averbuch-Heller L., Ben-Hur T., Reches A. Valproate encephalopathy and hypocarnitinaemia in diabetic patients. J. Neurol. 241:1994;567-569.
2. Ballaban-Gil K., Callahan C., O'Dell C., Pappo M., Moshe S., Shinnar S. Complications of the ketogenic diet. Epilepsia. 39:1998;744-748.
3. Cahill G.F., Herrera M.G., Morgan A.P. Hormone-fuel relationships during fasting. J. Clin. Invest. 45:1966;1751-1767.
4. Chez M.G., Buchanon C., Kessler J., Demski P., Wagner E. Carnitine deficiency in patients starting the ketogenic diet. Neurology. 48:1997;A110.
5. Coulter D.L. Carnitine deficiency in epilepsy: risk factors and treatment. J. Child. Neurol. 10(2):1995;S32-S39.
6. Demeritte E.L., Ventimiglia J., Coyne M., Nigro M.A. Organic acid disorders and the ketogenic diet. Ann. Neurol. 40:1996;305.
7. De Vivo D.C., Bohan T.P., Coulter D.L., Dreifuss F.E., Greenwood R.S., Nordli D.R. Jr., Shields W.D., Stafstrom C.E., Tein I. L-Carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia. 39:1998;1216-1225.
8. De Vivo D.C., Haymond M.W., Leckie M.P., Bussman Y.L., McDougal D.B. Jr., Pagliara A.S. The clinical and biochemical implications of pyruvate carboxylase deficiency. J. Clin. Endocrinol. Metab. 45:1977;1281-1296.
9. De Vivo D.C., Pagliara A.S., Prensky A.L. Ketotic hypoglycemia and the ketogenic diet. Neurology. 23:1973;640-649.
10. De Vivo D.C., Trifiletti R.R., Jacobson R.L., Ronen G.M., Behmand R.A., Harik S.I. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay [see comments]. N. Engl. J. Med. 325:1991;703-709.
11. De Vivo D.C., Tein I. Primary and secondary disorders of carnitine metabolism. Int. Pediatr. 5:1990;134-141.
12. Falk R.E., Cederbaum S.D., Blass J.P., Gibson G.E., Kark R.A., Carrel R.E. Ketonic diet in the management of pyruvate dehydrogenase deficiency. Pediatrics. 58:1976;713-721.
13. Gjedde A., Crone C. Induction processes in blood-brain transfer of ketone bodies during starvation. Am. J. Physiol. 229:1975;1165-1169.
14. Hahn T.J., Halstead L.R., DeVivo D.C. Disordered mineral metabolism produced by ketogenic diet therapy. Calcif. Tissue Int. 28:1979;17-22.
15. Kossak B.D., Schmidt-Sommerfeld E., Schoeller D.A., Rinaldo P., Penn D., Tonsgard J.H. Impaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine. Neurology. 43:1993;2362-2368.
16. Laub M.C., Paetzke-Brunner I., Jaeger G. Serum carnitine during valproic acid therapy. Epilepsia. 27:1986;559-562.
17. Lyon G., Adams R.D., Kolodny E.H. Neurology of Hereditary Metabolic Diseases of Children. 1996;McGraw-Hill, New York.
18. Nordli D.R. Jr., De Vivo D.C. The ketogenic diet revisited: back to the future. Epilepsia. 38:1997;743-749. Editorial comment.
19. Cahill G.F., Herrera M.G., Morgan A.P. Hormone-fuel relationships during fasting. J. Clin. Invest. 45:1966;1751-1767.
20. Riva R., Albani F., Gobbi G., Santucci M., Baruzzi A. Carnitine disposition before and during valproate therapy in patients with epilepsy. Epilepsia. 34:1993;184-187.
21. Riva R., Zaccara G., Albani F., Galli G., Campostrini R., Paganini M., Baruzzi A. Effects of acute valproic acid administration on carnitine plasma concentrations in epileptic patients. Epilepsy Res. 8:1991;149-152.
22. Rutledge S.L., Kinsman S.L., Geraghry M.T., Vining E.P.G., Thomas G. Hypocarnitinemia and the ketogenic diet. Ann. Neurol. 26:1989;472.
23. Shapira Y., Gutman A. Muscle carnitine deficiency in patients using valproic acid [see comments]. J. Pediatr. 118:1991;646-649.
24. Stanley C.A., Hale D.E., Berry G.T., Deleeuw S., Boxer J., Bonnefont J.P. Brief report: a deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N. Engl. J. Med. 327:1992;19-23.
25. Swoboda K.J., Specht L., Jones H.R., Shapiro F., DiMauro S., Korson M. Infantile phosphofructokinase deficiency with arthrogryposis: clinical benefit of a ketogenic diet. J. Pediatr. 131:1997;932-934.
26. Toksoy H.B., Tanzer F.N., Atalay A. Serum carnitine, β-hydroxybutyrate and ammonia levels during valproic acid therapy. Turk. J. Pediatr. 37:1995;25-29.
27. Tyni T., Palotie A., Viinikka L., Valanne L., Salo M.K., von Dobeln U., Jackson S., Wanders R., Venizelos N., Pihko H. Long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G 1528C mutation: clinical presentation of 13 patients. J. Pediatr. 130:1997;67-76.
28. Wexler I.D., Hemalatha S.G., McConnell J., Buist N.R., Dahl H.H., Berry S.A., Cederbaum S.D., Patel M.S., Kerr D.S. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology. 49:1997;1655-1661.
29. Wijburg F.A., Barth P.G., Bindoff L.A., Birch-Machin M.A., van der Blij J.F., Ruitenbeek W., Turnbull D.M., Schutgens R.B. Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet. Neuropediatrics. 23:1992;147-152.
30. Zelnik N., Fridkis I., Gruener N. Reduced carnitine and antiepileptic drugs: cause relationship or co-existence? Acta Paediatr. 84:1995;93-95.